JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB210693

Anti-GPCR GPR39 antibody

Be the first to review this product! Submit a review

|

(2 Publications)

Goat Polyclonal GPCR GPR39 antibody. Suitable for WB and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Synthetic Peptide within Human GPR39 aa 350-400.

View Alternative Names

G-protein coupled receptor 39, GPR39

1 Images
Western blot - Anti-GPCR GPR39 antibody (AB210693)
  • WB

Supplier Data

Western blot - Anti-GPCR GPR39 antibody (AB210693)

Primary incubation was 1 hour.

All lanes:

Western blot - Anti-GPCR GPR39 antibody (ab210693) at 0.3 µg/mL

All lanes:

Human cerebellum tissue lysate at 35 µg

Predicted band size: 51 kDa

Observed band size: 50 kDa

true

Key facts

Host species

Goat

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

Synthetic Peptide within Human GPR39 aa 350-400. The exact immunogen used to generate this antibody is proprietary information.

O43194

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.3-1 µg/mL", "WB-species-notes": "<p>1 hour primary incubation is recommended for this product.</p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
ab210693 was purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Storage buffer
pH: 7.3 Preservative: 0.02% Sodium azide Constituents: 99% Tris buffered saline, 0.5% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GPR39 also known as G-protein coupled receptor 39 is a member of the G-protein coupled receptor (GPCR) family which play important roles in signaling mechanisms in cells. This receptor has a mass of approximately 53 kDa. It is expressed in multiple human tissues with a significant presence in the gastrointestinal tract kidney and pancreas. GPR39 is involved in binding zinc ions which suggests a regulatory role under physiological conditions where zinc concentrations fluctuate.
Biological function summary

GPR39 influences various physiological processes related to metabolic and homeostatic functions in the body. It is not part of a complex but operates as a standalone receptor that activates diverse intracellular pathways upon ligand binding. The receptor has reported roles in regulating appetite influencing glucose metabolism and maintaining energy balance. Through the modulation of different cellular signals GPR39 helps in controlling processes like gastric acid secretion and insulin sensitivity.

Pathways

Researchers recognize GPR39’s involvement in the Wnt signaling and mTOR signaling pathways. In the context of the Wnt pathway GPR39 interfaces through interactions with other signaling molecules and proteins like beta-catenin which underpins its role in cellular growth and differentiation. Meanwhile in the mTOR pathway its interaction influences protein synthesis and cellular metabolism. These pathways highlight the receptor's pivotal role in various biological processes.

GPR39's functional implications extend to conditions such as metabolic syndrome and gastrointestinal disorders. Its regulation of metabolic processes links it to metabolic syndrome where insulin resistance and glucose homeostasis are disrupted. Additionally in gastrointestinal disorders changes in its expression or function relate to conditions like irritable bowel syndrome (IBS). Interactions with proteins such as ghrelin and insulin highlight its extensive influence as these proteins are essential for metabolic and appetite regulation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Zinc-sensing receptor that can sense changes in extracellular Zn(2+), mediate Zn(2+) signal transmission, and participates in the regulation of numerous physiological processes including glucose homeostasis regulation, gastrointestinal mobility, hormone secretion and cell death (PubMed : 18180304). Activation by Zn(2+) in keratinocytes increases the intracellular concentration of Ca(2+) and activates the ERK/MAPK and PI3K/AKT signaling pathways leading to epithelial repair (PubMed : 20522546). Plays an essential role in normal wound healing by inducing the production of cytokines including the major inflammatory cytokine IL6 via the PKC/MAPK/CEBPB pathway (By similarity). Regulates adipose tissue metabolism, especially lipolysis, and regulates the function of lipases, such as hormone-sensitive lipase and adipose triglyceride lipase (By similarity). Plays a role in the inhibition of cell death and protects against oxidative, endoplasmic reticulum and mitochondrial stress by inducing secretion of the cytoprotective pigment epithelium-derived growth factor (PEDF) and probably other protective transcripts in a GNA13/RHOA/SRE-dependent manner (PubMed : 18180304). Forms dynamic heteroreceptor complexes with HTR1A and GALR1 depending on cell type or specific physiological states, resulting in signaling diversity : HTR1A-GPR39 shows additive increase in signaling along the serum response element (SRE) and NF-kappa-B pathways while GALR1 acts as an antagonist blocking SRE (PubMed : 26365466).
See full target information GPR39

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Experimental and therapeutic medicine 22:1246 PubMed34539842

2021

Suppressing TRAP1 sensitizes glioblastoma multiforme cells to temozolomide.

Applications

Unspecified application

Species

Unspecified reactive species

Nan Wang,Peining Zhu,Renxuan Huang,Liankun Sun,Delu Dong,Yufei Gao

Cell biology international 45:1211-1219 PubMed33554444

2021

GPR39 promotes cardiac hypertrophy by regulating the AMPK-mTOR pathway and protein synthesis.

Applications

Unspecified application

Species

Unspecified reactive species

Hongjuan Liao,Weinian Gao,Jie Ma,Hongyuan Xue,Yi Wang,Dai Huang,Fang Yan,Yuquan Ye
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com